Dr Sulaiman Al Habib grows first half revenue to 7.4 billion riyals

There is a particular kind of good news that comes with an asterisk, and Dr Sulaiman Al Habib Medical Services Group's first half of 2026 is a clean example. The Riyadh listed hospital operator, known on the Tadawul simply as HMG, lifted its revenue to roughly 7.4 billion riyals in the six months to the end of June, up from about 6.54 billion riyals in the same period a year earlier, a rise of around 13 percent. That top line growth is real and it is broad based. What sits underneath it, though, is a more nuanced story about a company spending heavily to expand and absorbing the cost of that expansion in its margins before the payoff arrives. The two quarters that make up the half tell slightly different stories. The first quarter was the awkward one, with revenue of about 3.44 billion riyals but net profit falling roughly 9.6 percent year on year to 503.3 million riyals. The company was candid about why. It had added around 2,000 hospital beds across new facilities during 2024 and 2025, and those newly commissioned hospitals were still in what management calls the ramp-up phase, carrying higher depreciation and financing costs while not yet running at full patient volumes. Seasonal factors weighed on the quarter too. The second quarter then reversed the profit trend cleanly, with net profit climbing about 12 percent year on year to 662.6 million riyals on revenue of roughly 3.96 billion riyals. Put the two together and HMG made in the region of 1.17 billion riyals in net profit for the half, up modestly on the 1.14 billion riyals it earned in the first half of 2025. The pattern is one of a company whose revenue engine is running hard while its profitability catches up quarter by quarter as new capacity fills. The strategic logic behind that squeeze is worth spelling out, because it is deliberate rather than accidental. HMG operates across three segments, hospitals, pharmacies and a solutions arm that handles everything from home healthcare and third party facility management to IT and cloud services, and growth has been coming across all three. Founded in 1995 by the pediatrician Dr Sulaiman Al Habib, who still owns around 40 percent of the group after its 2020 listing, the company has leaned into an aggressive build out, approving two new integrated hospital projects in Riyadh and Dammam late last year with a combined value of nearly 1.97 billion riyals. A hospital is a long lead time asset that costs money to build and staff well before it earns its keep, so a growth phase like this mechanically depresses margins even as it expands revenue. The company continued rewarding shareholders throughout, distributing 465.5 million riyals in cash dividends for the second quarter, a sign that management is comfortable the ramp-up is a timing issue rather than a structural one. Al Habib's own fortune, estimated by Forbes at around 11.2 billion dollars, is closely tied to how that bet plays out. The regional context explains why HMG is willing to accept a period of margin compression to grab capacity now. Saudi Arabia is undergoing a structural expansion of private healthcare demand, driven by a growing and ageing population, the gradual shift of medical provision from the public to the private sector, and a Vision 2030 health agenda that explicitly wants private operators to shoulder more of the load. HMG is not confined to the Kingdom either, running hospitals and clinics in Dubai and Bahrain alongside its Saudi network, which gives it exposure to the broader Gulf medical tourism and premium care market. It competes in a regional field that is consolidating and professionalizing fast, with players like the UAE's PureHealth, which posted revenues above 12 billion dirhams, and other listed Gulf hospital groups all racing to add beds and specialized centers in areas such as fertility, oncology and obesity treatment. Against that backdrop, HMG's half year reads less like a company straining and more like one investing through a growth window while its competitors do the same. The honest question for investors is one of patience. The revenue trajectory is clearly intact and the second quarter profit rebound suggests the ramp-up is proceeding as planned, but the full return on those 2,000 new beds and the Riyadh and Dammam projects will only show up once occupancy climbs toward optimal levels. Until then, HMG is a company growing its top line convincingly while asking the market to wait a few more quarters for the bottom line to fully follow.